Literature DB >> 10720599

Overweight and hypertension : a 2-way street?

S Julius1, M Valentini, P Palatini.   

Abstract

Cross-sectionally, higher weight is associated with higher blood pressure levels; prospectively, baseline weight and weight gain predict higher blood pressure. The loss of weight is frequently associated with a decrease in blood pressure. These findings suggest that weight gain may pathophysiologically contribute to blood pressure elevation. In this review, we present data to indicate that the reverse is also true; persons of equal weight who had higher initial blood pressures gain more weight in the future. We also propose a plausible hypothesis to explain this reverse relationship. Both the blood pressure elevation and the gain of weight may reflect a primary increase in sympathetic tone. It is well known that in a milieu of increased sympathetic tone, the beta-adrenergic responsiveness decreases. Sympathetic overactivity and decreased cardiovascular beta-adrenergic responsiveness have been described in hypertension. beta-Adrenergic receptors mediate increases in energy expenditure. If these metabolic receptors were downregulated in hypertension, the ability of hypertensive patients to dissipate calories would decrease and they would gain more weight. The possible relationship of decreased beta-adrenergic responsiveness to weight in hypertension can be experimentally tested. Such research may contribute to an explanation of why patients with hypertension can rarely lose weight. An understanding of this pathophysiological relationship may open new avenues for therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720599     DOI: 10.1161/01.hyp.35.3.807

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  57 in total

Review 1.  Obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin.

Authors:  Kazuko Masuo
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

Review 2.  Autonomic dysfunction in programmed hypertension.

Authors:  Hasthi U Dissanayake; Michael R Skilton; Jaimie W Polson
Journal:  J Hum Hypertens       Date:  2018-12-05       Impact factor: 3.012

Review 3.  Discrepancies in office and ambulatory blood pressure in adolescents: help or hindrance?

Authors:  Empar Lurbe; Josep Redon
Journal:  Pediatr Nephrol       Date:  2007-08-11       Impact factor: 3.714

Review 4.  The role of cardiac autonomic function in hypertension and cardiovascular disease.

Authors:  Paolo Palatini; Stevo Julius
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

Review 5.  Mediators of sympathetic activation in metabolic syndrome obesity.

Authors:  Nora E Straznicky; Nina Eikelis; Elisabeth A Lambert; Murray D Esler
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

6.  Analysis for hypertension and related risk factors of physical examination population.

Authors:  Sen Qiao; Qing Ye; Yue Dou; Mingzi Li; Yuhong Kou; Dawei Qian; Mingcheng Li; Gang Wang
Journal:  Int J Clin Exp Med       Date:  2013-09-25

Review 7.  Hypertension in black patients: special issues and considerations.

Authors:  Shawna D Nesbitt
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

Review 8.  Neural mechanisms and management of obesity-related hypertension.

Authors:  Murray D Esler; Nina Eikelis; Elisabeth Lambert; Nora Straznicky
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

Review 9.  Hypertension in black patients: special issues and considerations.

Authors:  Shawna D Nesbitt
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

10.  Association between nocturnal blood pressure dipping and insulin resistance in children affected by NAFLD.

Authors:  Ugo Giordano; Claudia Della Corte; Giulia Cafiero; Daniela Liccardo; Attilio Turchetta; Kazem Mohammad Hoshemand; Danilo Fintini; Giorgio Bedogni; Maria Chiara Matteucci; Valerio Nobili
Journal:  Eur J Pediatr       Date:  2014-06-17       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.